Six-week outcomes after pegaptanib.
Schuman
Stefanie
S
Rogers
Adam H
AH
Duker
Jay S
JS
Reichel
Elias
E
Baumal
Caroline R
CR
D052157:Aptamers, Nucleotide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008268:Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity; D014822:Vitreous Body
D052157:Aptamers, Nucleotide; C495058:pegaptanib